IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of ...
BRENTWOOD, Tenn., Sept. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) ("IMAC" or "the Company"), today announces it has completed the third cohort of its Phase 1…
